Stockscreener 앱 받기
2.12%
전일 마감가:
$51.05
열려 있는:
$50.32
하루 거래량:
2.79M
Relative Volume:
0.51
시가총액:
$13.19B
수익:
$14.00B
순이익/손실:
$1.26B
주가수익비율:
10.25
EPS:
4.8749
순현금흐름:
$352.00M
1주 성능:
-0.70%
1개월 성능:
+6.71%
6개월 성능:
-18.81%
1년 성능:
+59.70%
1일 변동 폭
$49.86
$50.72
1주일 범위
$49.07
$52.58
52주 변동 폭
$30.71
$84.38
알코아 Stock (AA) Company Profile
명칭
Agilent Technologies Inc
전화
412-315-2900
주소
201 ISABELLA STREET, PITTSBURGH, PA
Compare AA vs TMO, DHR, NTRA, IQV, A
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AA
Agilent Technologies Inc
|
49.97 | 13.34B | 14.00B | 1.26B | 352.00M | 4.8749 |
TMO
Thermo Fisher Scientific Inc
|
613.78 | 232.03B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
207.66 | 151.78B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
328.18 | 46.82B | 2.50B | -226.32M | 71.51M | -1.6412 |
IQV
Iqvia Holdings Inc
|
267.77 | 42.15B | 16.63B | 1.39B | 2.12B | 8.0674 |
A
Agilent Technologies Inc
|
150.86 | 44.14B | 7.23B | 1.41B | 1.09B | 4.979 |
알코아 Stock (AA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-04-09 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2026-03-13 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2026-01-27 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2026-01-13 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2026-01-08 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2025-10-08 | 개시 | Wells Fargo | Overweight |
| 2025-07-08 | 재개 | Citigroup | Buy |
| 2025-05-15 | 다운그레이드 | UBS | Buy → Neutral |
| 2025-04-08 | 다운그레이드 | BofA Securities | Buy → Underperform |
| 2024-10-23 | 업그레이드 | Argus | Hold → Buy |
| 2024-10-17 | 업그레이드 | B. Riley Securities | Neutral → Buy |
| 2024-10-01 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2024-09-25 | 재개 | JP Morgan | Neutral |
| 2024-09-04 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2024-08-12 | 업그레이드 | UBS | Sell → Buy |
| 2024-08-02 | 업그레이드 | Wolfe Research | Underperform → Peer Perform |
| 2024-06-21 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2024-04-22 | 업그레이드 | Morgan Stanley | Underweight → Equal-Weight |
| 2024-01-16 | 개시 | UBS | Sell |
| 2023-12-07 | 개시 | HSBC Securities | Hold |
| 2023-10-23 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2023-07-24 | 다운그레이드 | Argus | Buy → Hold |
| 2023-07-14 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2023-07-11 | 다운그레이드 | Wolfe Research | Peer Perform → Underperform |
| 2023-06-22 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2023-05-11 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2023-05-08 | 개시 | JP Morgan | Overweight |
| 2023-02-22 | 업그레이드 | Citigroup | Neutral → Buy |
| 2023-01-19 | 재확인 | B. Riley Securities | Neutral |
| 2022-12-09 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2022-10-07 | 개시 | UBS | Neutral |
| 2022-09-22 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2022-09-16 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2022-04-21 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-04-08 | 다운그레이드 | Credit Suisse | Outperform → Neutral |
| 2022-03-24 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-11 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2021-11-17 | 개시 | Wolfe Research | Outperform |
| 2021-11-02 | 업그레이드 | Jefferies | Hold → Buy |
| 2021-10-05 | 재확인 | JP Morgan | Overweight |
| 2021-09-29 | 재확인 | Morgan Stanley | Overweight |
| 2021-09-15 | 업그레이드 | Argus | Hold → Buy |
| 2021-07-16 | 업그레이드 | Citigroup | Neutral → Buy |
| 2021-04-23 | 재개 | JP Morgan | Overweight |
| 2021-03-24 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2021-03-17 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2021-03-03 | 업그레이드 | Goldman | Sell → Buy |
| 2020-09-08 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2020-06-16 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2020-03-24 | 다운그레이드 | B. Riley FBR | Buy → Neutral |
| 2020-03-04 | 업그레이드 | BofA/Merrill | Underperform → Neutral |
| 2020-01-17 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2019-12-17 | 다운그레이드 | BMO Capital Markets | Outperform → Market Perform |
| 2019-11-13 | 다운그레이드 | BofA/Merrill | Neutral → Underperform |
| 2019-11-12 | 재확인 | B. Riley FBR | Buy |
| 2019-11-07 | 재개 | Morgan Stanley | Equal-Weight |
| 2019-10-21 | 다운그레이드 | Gabelli & Co | Buy → Hold |
| 2019-09-26 | 재확인 | B. Riley FBR | Buy |
| 2019-09-23 | 다운그레이드 | Goldman | Buy → Neutral |
| 2019-09-11 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2019-08-16 | 재확인 | BofA/Merrill | Neutral |
| 2019-07-19 | 다운그레이드 | Argus | Buy → Hold |
| 2019-07-11 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2019-07-09 | 다운그레이드 | Macquarie | Outperform → Neutral |
| 2019-04-22 | 업그레이드 | Gabelli & Co | Hold → Buy |
| 2019-04-03 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2019-04-02 | 다운그레이드 | Credit Suisse | Outperform → Neutral |
모두보기
알코아 주식(AA)의 최신 뉴스
Price to sales forward of Agilent Technologies, Inc. – MIL:1A - TradingView
Agilent Technologies stock gains as FDA-cleared S540MD slide scanner strengthens digital pathology p - AD HOC NEWS
Agilent Technologies | 144: Notice of proposed sale of securities pursuant to Rule 144 - Moomoo
Mikael Dolsten to sell Agilent (NYSE: A) stock - stocktitan.net
Worker says Agilent fired him to mask race and age bias - hcamag.com
Agilent Technologies stock gains on digital pathology launch and strong Q3 figures - AD HOC NEWS
Agilent Expands Digital Pathology Offering with U.S. Launch of the Agilent S540MD Slide Scanner System - 01net
Agilent Technologies Launches FDA-Cleared S540MD Slide Scanner in US - marketscreener.com
Agilent launches FDA-cleared slide scanner in U.S. market By Investing.com - Investing.com Australia
Baird Adjusts Price Target on Agilent Technologies to $180 From $169, Keeps Outperform Rating - marketscreener.com
Agilent Technologies Inc (A) Looks 2.6% Overvalued on GF Value™ - GuruFocus
Agilent: The Recovery Is Real, But So Is The Valuation (NYSE:A) - Seeking Alpha
A SWOT Analysis: Agilent Technologies Inc (A) Reveals Financial Insights in 10-Q Filing - GuruFocus
Bond swap: Agilent (NYSE: A) offers to exchange $600M in 4.9% notes - stocktitan.net
Agilent (NYSE: A) readies global debt program with $100M default triggers - stocktitan.net
Agilent Technologies 3Q 2026: Revenue $1.88B, EPS $1.28— 10-Q Summary - TradingView
Agilent (NYSE: A) spends $950M on Biocare — see how Q3 earnings and debt shifted - stocktitan.net
Agilent Introduces the Cary 635 FTIR Spectrometer - Yahoo Finance
Agilent Technologies, Inc. Introduces The Cary 635 FTIR Spectrometer - marketscreener.com
Agilent launches Cary 635 FTIR spectrometer for laboratories - Investing.com
HSBC Adjusts Price Target on Agilent Technologies to $175 From $165, Maintains Buy Rating - marketscreener.com
AGILENT TECHNOLOGIES INC : HSBC RAISES TARGET PRICE TO $175 FROM $165 - Bitget
International Markets and Agilent (A): A Deep Dive for Investors - Yahoo Finance
Weekly Recap: Agilent (A) Q3 results and pharma reshoring opportunity - TradingView
Stronger Q3 Results and Raised Guidance Could Be A Game Changer For Agilent Technologies (A) - Sahm
Agilent Technologies Inc. stock underperforms Friday when compared to competitors - MarketWatch
Wells Fargo Adjusts Price Target on Agilent Technologies to $180 From $160, Keeps Overweight Rating - Moomoo
Agilent (NYSE) Expanded Non-GAAP Margin 320 bps. How Much Is Repeatable? - Yahoo Finance
Rothschild & Co Redburn Adjusts Agilent Technologies Price Target to $180 From $160, Maintains Buy Rating - Moomoo
Agilent Technologies: Q3 Growth, Expanding Margins, And Raised Guidance - Seeking Alpha
Agilent Technologies beats estimates, raises guidance on strong demand; shares up - Investing.com
AGILENT TECHNOLOGIES INC : RBC RAISES TARGET PRICE TO $185 FROM $155 - Bitget
Agilent Technologies Q3 Earnings Call Highlights - Yahoo Finance
Transcript : Agilent Technologies, Inc., Q3 2026 Earnings Call, Aug 26, 2026 - marketscreener.com
Is Agilent Technologies Inc (A) Overvalued After Q3 Earnings? EP - GuruFocus
Agilent: Fiscal Q3 Earnings Snapshot - 10TV
Agilent Technologies, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2026 - marketscreener.com
Agilent Reports Third-Quarter Fiscal Year 2026 Financial Results - Business Wire
Agilent Technologies (A) is a Great Momentum Stock: Should You Buy? - Yahoo Finance
Agilent Technologies Slides Ahead of Earnings as Investors Appear Cautious - Moomoo
Agilent Technologies Inc. Stock Slips 3.5%, Underperforms Peers - Bitget
Why Agilent Technologies (A) Is Up 7.0% After Q2 Beat And Higher 2026 GuidanceAnd What's Next - simplywall.st
Agilent Technologies stock hits 52-week high at 160.36 USD - Investing.com
Agilent Stock Has A Catalyst Coming On August 26 That Investors Should Not Ignore - 24/7 Wall St.
Exploring Analyst Estimates for Agilent (A) Q3 Earnings, Beyond Revenue and EPS - Yahoo Finance
Agilent Technologies (A) Q3 2026 Preview: EPS Est. $1.44, Reports August 26 - AlphaStreet
Agilent Technologies stock trades close to 12?month high as guidance and analyst consensus support o - Ad-hoc-news.de
Agilent Technologies stock gains after fresh analyst target lift and regulatory filing - Ad-hoc-news.de
A5143230 Bond Profile — Key Metrics - TradingView
What Are Wall Street Analysts' Target Price for Agilent Technologies Stock? - inkl
Agilent Technologies (A) Gains Attention In Cannabis Testing, Is It Fully Valued? - simplywall.st
알코아 (AA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.39%
1.15%
자본화:
|
볼륨(24시간):